论文部分内容阅读
目的观察疏血通联合神经节苷脂注射液对脑梗死神经功能恢复的影响。方法脑梗死患者100例,随机均分为疏血通联合神经节苷脂注射液对治疗组和单用神经节苷脂注射液对照组,治疗前后进行临床神经功能缺损(NIHSS)评分、日常生活能力(ADL)评分及血液流变学测定。结果治疗后,治疗组NIHSS评分低于对照组[(4.64±1.26)分vs.(6.07±1.77)分](P<0.05),ADL评分高于对照组[(67.34±5.62)分vs.(52.35±3.78)分](P<0.05),治疗组血液流变学参数均低于对照组(P<0.05)。治疗组临床总有效率高于对照组(90%vs.68%)(P<0.05)。结论疏血通联合神经节苷脂注射液对治疗脑梗死较单药神经节苷脂注射液对更能明显降低血液黏稠度,促进神经功能恢复,改善患者生活自理能力。
Objective To observe the effect of Shuxuetong combined with ganglioside injection on neurological function recovery after cerebral infarction. Methods A total of 100 patients with cerebral infarction were randomly divided into two groups: Shuxuetong ganglioside injection and control group. The clinical neurological deficit (NIHSS) score was assessed before and after treatment. Daily life Ability (ADL) score and hemorheology. Results After treatment, the NIHSS score of the treatment group was lower than that of the control group [(4.64 ± 1.26) vs. (6.07 ± 1.77) min] (P <0.05), ADL score was higher than that of the control group [(67.34 ± 5.62) vs. 52.35 ± 3.78) points (P <0.05). The parameters of hemorheology in the treatment group were lower than those in the control group (P <0.05). The total effective rate of treatment group was higher than that of control group (90% vs.68%) (P <0.05). Conclusion Shuxuetong combined with ganglioside injection for the treatment of cerebral infarction than monotherapy ganglioside injection can significantly reduce blood viscosity, promote neurological recovery, improve patients’ ability to take care of themselves.